BioCentury
ARTICLE | Financial News

Antibiotics play Melinta raises about $35 million

February 11, 2014 2:21 AM UTC

Melinta Therapeutics Inc. (New Haven, Conn.) raised about $35 million of a planned $70 million in a tranched venture round led by existing investor Vatera Healthcare Partners. New investor Falcon Flight participated along with undisclosed existing and new investors. Melinta (formerly Rib-X Pharmaceuticals Inc.) is developing delafloxacin, a broad spectrum fluoroquinolone antibiotic. ...